LPS: Clinical Trials

36 trials of LPS, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

26 completed, 3 terminated, 2 not yet recruiting, 2 recruiting. 15 Not applicable, 13 Phase 1, 3 Early Phase 1, 3 Phase 4, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable15Completed 12, Not yet recruiting 1, Recruiting 1, Unknown 1
Phase 113Completed 7, Terminated 3, Not yet recruiting 1, Recruiting 1, Withdrawn 1
Early Phase 13Completed 3
Phase 43Completed 2, Unknown 1
Phase 22Completed 1, Recruiting 1
Phase 31Completed 1

Follow LPS: new trials by email Literature Review of LPS trials Research Report on LPS

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Spleen Preservation Versus Splenectomy in Left Pancreatectomy for Pancreatic Ductal Adenocarcinoma (SPLENDID)
SPLP, LPS - Pancreatic Cancer, Pancreatectomy
Not applicableNot yet recruitingAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)3602026-11-012026-09-02
Short-Chain Fatty Acids in Lypopolysaccharide-Induced Inflammation and Executive Function
Short-Chain Fatty Acid Colon-Delivery Capsules, Placebo capsules, Lipopolysaccharide (LPS) - Endotoxemia, Inflammation
Not applicableRecruitingUniversitaire Ziekenhuizen KU Leuven562025-10-242026-07-20
Brain Biomarker on Inflammation Response
LPS, Placebo - Schizophrenia
Phase 1WithdrawnUniversity of Maryland, Baltimore2025-01-012023-12-05
Immunomodulatory Effects of Dexamethasone, Tocilizumab and Anakinra During Experimental Human Endotoxemia
Dexamethasone, Tocilizumab, Anakinra - Sepsis, Neuroinflammatory Response
Phase 4UnknownRadboud University Medical Center522024-10-242025-04-04
Nasal Inflammation Following Endotoxin Challenge in Patients With Asthma
Lipopolysaccharides - Asthma; Eosinophilic, Asthma
Phase 1Not yet recruitingNational Jewish Health602024-04-012024-02-21
Neural Response to Inflammatory Challenge in Major Depressive Disorder
LPS, Saline - Major Depressive Disorder
Phase 1 / Phase 2RecruitingLaureate Institute for Brain Research, Inc.1802021-05-152026-04-21
CBD-Microglia PET Study
[11C]PBR28, Low-dose lipopolysaccharide, Intradermal Capsaicin - CBD, Healthy
Early Phase 1CompletedYale University282021-05-072026-04-29
Determining the Fingerprint of Endotoxin Tolerance
Endotoxin (E. coli O:113, Reference Endotoxin) - Endotoxemia, Sepsis
Not applicableCompletedRadboud University Medical Center1102019-05-272025-02-07
A Study Exploring the Use of Vaccine and Antigen Challenges for Immune Monitoring in Healthy Participants
Imvanex, Shingrix, LPS - Healthy
Early Phase 1CompletedJanssen Research & Development, LLC482019-04-082025-02-03
Intradermal LPS and Antibiotics
Erythromycin 4% topical gel formulation:, Clindamycin 1% lotion formulation:, Prednisolone tablet (0.5mg/kg; parallel comparison): - Inflammation; Skin
Not applicableCompletedCentre for Human Drug Research, Netherlands322018-10-122021-08-03
Peripheral Benzodiazepine Receptors (PBR28) Brain PET Imaging With Lipopolysaccharide Challenge for the Study of Microglia Function in Alzheimer's Disease
LPS - Alzheimer Disease
Early Phase 1CompletedYale University182018-04-152024-02-05
First-time-in-Human (FTIH) Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single (in Both Fed and Fasted States) or Repeat Doses of GSK3358699
Placebo, GSK3358699, GM-CSF - Arthritis, Rheumatoid
Phase 1TerminatedGlaxoSmithKline482018-03-132020-12-02
The Effects of Human Endotoxemia on Functional Capacity of Hematopoietic Stem and Progenitor Cells
LPS, Placebo - Sepsis, Endotoxemia, Immunosuppression
Not applicableCompletedRadboud University Medical Center122018-01-052022-10-06
Imaging the Neuroimmune System in PTSD
Lipopolysaccharide - Post Traumatic Stress Disorder
Phase 1CompletedYale University342017-03-282024-12-09
Adrecizumab-LPS Study
Endotoxin, Placebo, Adrecizumab - Healthy Volunteers
Phase 1CompletedAdrenomed AG242017-01-042021-02-01
Dose-Related Inflammatory Effects of Intravenous Endotoxin in Humans
Endotoxin, Placebo - Healthy
Phase 1CompletedRobert J Noveck, M.D.232016-08-012017-04-11
Vorapaxar in the Human Endotoxemia Model
Vorapaxar, Placebo, LPS - Healthy Volunteers
Phase 4CompletedMedical University of Vienna162016-06-012020-01-10
The Effects of Preceding LPS Administration on the Fluenz-induced Immune Response
Fluenz, placebo, LPS - Innate Immune Response, Immune Tolerance
Not applicableCompletedRadboud University Medical Center302015-12-012019-05-14
Endotoxin-induced Inflammatory and Behavioral Responses and Predictors of Individual Differences
Endotoxin, Placebo - Sickness Behavior
Not applicableCompletedKarolinska Institutet222015-02-012015-08-20
A Study of Intracellular Signaling in Muscle and Fat Cells During Ketosis
LPS - Ketoacidosis, Diabetes Mellitus Type 1
Not applicableCompletedUniversity of Aarhus92014-06-012015-12-02

Showing 20 of 36. Sign in to see all of them.

Conditions studied

Endotoxemia (9)  ·  Inflammation (4)  ·  Sepsis (4)  ·  Illness Behavior (3)  ·  Asthma (2)  ·  Alzheimer Disease (1)  ·  Anemia (1)  ·  Arthritis, Rheumatoid (1)  ·  Depressive Disorder, Major (1)  ·  Dermatitis (1)  ·  Diabetes Mellitus, Type 1 (1)  ·  Hypersensitivity (1)  ·  Infections (1)  ·  Inhibition, Psychological (1)  ·  Ketosis (1)

Sponsors

Radboud University Medical Center (8)  ·  Yale University (4)  ·  Karolinska Institutet (3)  ·  Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (2)  ·  GlaxoSmithKline (2)  ·  Medical University of Vienna (2)  ·  University of North Carolina, Chapel Hill (2)  ·  Adrenomed AG (1)  ·  Centre Hospitalier Universitaire Brugmann (1)  ·  Centre for Human Drug Research, Netherlands (1)  ·  Janssen Research & Development, LLC (1)  ·  Laureate Institute for Brain Research, Inc. (1)  ·  National Jewish Health (1)  ·  Pfizer (1)  ·  Robert J Noveck, M.D. (1)

Countries

United States (11)  ·  Netherlands (10)  ·  Belgium (3)  ·  United Kingdom (3)  ·  Austria (2)  ·  Denmark (1)

Top investigators

Peter Pickkers, MD, PhD (3)  ·  Kelly Cosgrove, PhD (2)  ·  Adam Mecca, M.D., Ph.D. (1)  ·  Alexandra Johnstone, Dr (1)  ·  Bart P Ramakers, MD (1)  ·  Bernd Jilma, MD (1)  ·  Boushra Dalile, PhD (1)  ·  Christa Firbas, MD (1)  ·  David B Peden, MD, MS (1)  ·  David Peden, MD (1)  ·  Jony van Hilst, MD, PhD (1)  ·  Kristin Verbeke, PhD (1)  ·  L E Hong, M.D. (1)

Results publications

PMID 22129171, PMID 25883989, PMID 27307305, PMID 27331367, PMID 28389705, PMID 29298938, PMID 29382797, PMID 30217536, PMID 30418539, PMID 33074729, PMID 34773923

NIH funding

1RC1ES018417 (1), 2017 (1), 2023 (1), K23AG057794 (1), R01HL073278 (1), R01MH110674 (1)